Creditors in the Danish food supplements company Fluxome, currently under reconstruction, have given the management carte blanche to negotiate a deal with Swiss outfit Evolva.
As Medwatch revealed a few weeks back, the deal concerns the right to produce the substance resveratrol, known as the health-beneficial substance found in red wine.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app